secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2025-07-11T23:59:59+00:00
Accession:  0001104659-25-067133
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rhythm Pharmaceuticals raises $188.7M in public equity offering; underwriters exercise full option
--------------------------------------------------------------------------------

- Offering of 2,058,824 shares at $85.00 per share; underwriters exercised 30-day option for 308,823 additional shares in full.
- Net proceeds expected to be approximately $188.7 million after underwriting discounts and expenses.
- Proceeds to advance clinical development of product candidates and commercialization activities for IMCIVREE, plus working capital.
- Company believes cash and short-term investments, including offering net proceeds, will fund operations for at least 24 months.
- Underwriting agreement with Morgan Stanley and BofA Securities as representatives of the underwriters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000110465925067133/0001104659-25-067133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000110465925067133/tm2520063d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-067133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer